Table 5.
Case # | % K19+ Extraportal Cholangiocytes with Vimentin Co-expression Only | % K19+ Extraportal Cholangiocytes with S100A4 Co-expression Only | % K19+ Extraportal Cholangiocytes with Vimentin and S100A4 Co-expression |
---|---|---|---|
PBC 1 | 20.0% (2/10) | 0.0% (0/10) | 20.0% (2/10) |
PBC 2 | 0.0% (0/5) | 40% (2/5) | 0.0% (0/5) |
PBC 3 | 27.3% (3/11) | 18.2% (2/11) | 18.2% (2/11) |
PBC 4 | 19.0 (4/21) | 0.0% (0/21) | 76.6% (16/21) |
PBC 5 | 38.4% (5/13) | 0.0% (0/13) | 15.4% (2/13) |
PBC 6 | 0.0% (0/15) | 6.7% (1/15) | 66.7% (10/15) |
PBC 7 | 18.1% (2/11) | 0.0% (0/11) | 81.9% (8/11) |
PBC 8 | 5.6% (1/18) | 27.8% (5/18) | 27.8% (5/18) |
PBC 9 | 20.0% (2/10) | 0.0% (0/10) | 80.0% (8/10) |
PBC 10 | 9.1% (1/11) | 45.5% (5/11) | 0.0% (0/11) |
PBC 11 | 12.0% (9/75) | 37.3% (28/75) | 20.0% (15/75) |
PBC 12 | 10.7% (7/65) | 27.6% (18/65) | 29.2% (19/65) |
PBC 13 | 15.1% (8/53) | 39.6% (21/53) | 24.5% (13/53) |
PBC 14 | 4.8% (3/62) | 45.2% (28/62) | 19.4% (12/62) |
Control 1 | 6.3% (1/16) | 0.0% (0/16) | 0.0% (0/16) |
Control 2 | 16.7% (2/12) | 58.3% (7/12) | 8.3% (1/12) |
Control 3 | 37.5% (6/16) | 62.5% (10/16) | 25.0% (4/16) |